The Influence of Reducing Diets on Changes in Thyroid Parameters in Obese Women With Hashimoto's Disease
NCT04752202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2021-02-15
Summary
Hashimoto's disease is listed among the most common endocrine causes of obesity. As treatment of obesity in women with Hashimoto's disease is frequently unsuccessful, the aim of this study was to evaluate the effectiveness of two different reducing diets and their influence on changes in thyroid parameters in the female patients. A six-month observational/interventional study was performed on 100 women aged 18-65 years, previously diagnosed with Hashimoto's disease and obesity and receiving L-thyroxine. The women were randomly assigned to the test group (group A, n=50) following elimination/reducing diets, and the control group (group B, n=50) following reducing diets with the same caloric content (without elimination). Anthropometric and thyroid parameters were evaluated at the beginning, after 3 months and after 6 months of treatment.
Conditions
- Hashimoto Disease
- Obesity
Interventions
- BEHAVIORAL
-
Individually balanced elimination/reducing diets
Participants received diets in the range of 1400-1600 kcal/day (with a deficit of about 1000 kcal/day, depending on the resting metabolism and energy expenditure during the day). At the initial visit and every subsequent month, the women received individually balanced elimination/reducing diets, in accordance with the previously performed food sensitivity tests for 6 months. Laboratory tests for type III food sensitivity in the IgG1-3 class using the ELISA method were performed in an accredited medical laboratory. Diets were designed by a qualified dietitian using the Aliant (Poland) diet calculator. Each diet had the same macronutrient content - 25% protein, 30% fat, and 45% carbohydrate, and met the daily requirements for micro and macro elements for the given age group.
- BEHAVIORAL
-
Individually balanced reducing diets (without elimination)
Participants received diets in the range of 1400-1600 kcal/day (with a deficit of about 1000 kcal/day, depending on the resting metabolism and energy expenditure during the day). At the initial visit and every subsequent month, the women received individually balanced reducing diets (without elimination) for 6 months.Diets were designed by a qualified dietitian using the Aliant (Poland) diet calculator. Each diet had the same macronutrient content - 25% protein, 30% fat, and 45% carbohydrate, and met the daily requirements for micro and macro elements for the given age group.
Sponsors & Collaborators
-
Medical University of Bialystok
lead OTHER
Principal Investigators
-
Lucyna Ostrowska, Professor · Medical University of Bialystok
-
Dominika Gier, PhD · Medical University of Bialystok
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-29
- Primary Completion
- 2019-04-19
- Completion
- 2019-10-31
Countries
- Poland
Study Locations
More Related Trials
-
Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease
NCT01102205 ·Status: COMPLETED
-
Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease
NCT04682340 ·Status: COMPLETED
-
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
NCT06373523 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Photobiomodulation Therapy in Patients With Hashimoto's Thyroiditis
NCT06735040 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Parameters in Euthyroid Patients With Thyroid Nodules
NCT00507897 ·Status: TERMINATED
-
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
NCT00360074 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D, Hashimato's Thyroiditis and Thyroid Functions
NCT06726967 ·Status: COMPLETED
-
Thyroid Hormones Effect on Brown Adipose Tissue
NCT01376648 ·Status: UNKNOWN
-
Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.
NCT07332273 ·Status: RECRUITING ·Phase: PHASE3
-
Correlation Between Thyroid Function and Quality of Life in Hypothyroidism
NCT04795947 ·Status: UNKNOWN
-
the Association Between Thyroid Hormones and Metabolic Components in Patients With Obesity
NCT04599374 ·Status: COMPLETED
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
The Relationship Between Urine Iodine, Urine Bisphenol A and Autoimmune Thyroid Disease in Reproductive Women
NCT03932487 ·Status: UNKNOWN
-
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism
NCT00531713 ·Status: COMPLETED ·Phase: PHASE4
-
Lipids Profile in Subclinical Hypothyroidism
NCT00962221 ·Status: TERMINATED
-
Hashimoto - a Surgical Disease. Total Thyroidectomy Makes Antibodies Disappear and Ameliorates Symptoms
NCT02319538 ·Status: COMPLETED ·Phase: NA
-
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
NCT00275171 ·Status: COMPLETED ·Phase: PHASE2
-
Hashimotos Thyroiditis and Thyroid Cancer
NCT01428167 ·Status: COMPLETED
-
Lipid Metabolic Status in Thyroid Carcinoma
NCT01487057 ·Status: COMPLETED
-
Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
NCT05501041 ·Status: ENROLLING_BY_INVITATION
-
Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone
NCT00715572 ·Status: COMPLETED ·Phase: NA
-
Influence of Thyroid Hormones on the Woundhealing Process
NCT00929318 ·Status: UNKNOWN ·Phase: NA
-
Relationship Between Thyroid Dysfunction and Diabetes
NCT07099937 ·Status: NOT_YET_RECRUITING
-
FGF-21 Levels and RMR in Children and Adolescents With Hashimoto's Thyroiditis (THYROMETABOL)
NCT02725879 ·Status: COMPLETED
-
Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
NCT05468554 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3